Back to search

France· FR:66904340

MELOXICAM BIOGARAN 7,5 mg, comprimé

A meloxicam product containing méloxicam, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC M01AC06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMELOXICAM BIOGARAN 7,5 mg, compriméATCM01AC06REGISTER NO.FR:66904340PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Meloxicam is registered in 16 of 19 countries.

Countries holding a registration under ATC M01AC06 (meloxicam), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Meloxicam · ATC M01AC06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of meloxicam costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.14 in Spain to $0.38 in France — a ×2.6 gap.

  • France: $0.38 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Meloxicam · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • FR France$0.38
  • IT Italy$0.23
  • ES Spain$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MÉLOXICAM
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
M01AC06
ATC class
Meloxicam
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400939660974
    plaquette(s) polyamide aluminium PVC de 14 comprimé(s)
    EUR 2.31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

442 interactions on record for meloxicam.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Meloxicam · interactions on record

442 records

  • 57 severe
  • 158 moderate
  • 1 minor
  • 144 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Meloxicam in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meloxicam products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Meloxicam G.L., Movalis
  • Belgium · Meloxicam Eg, Meloxicam Sandoz
  • Bulgaria · Мелбек, Мелбек Форт
  • Cyprus · Melgesic, Melorem
  • Czechia · Melocox, Meloxicam Teva
  • Germany · Meloxicam 1 A Pharma, Meloxicam Al
  • Denmark · Meloxicam Stada, Meloxicam Teva
  • Estonia · Melox, Movalis
  • Spain · Meloxicam Cinfa, Meloxicam Normon
  • Finland · Mobic
  • United Kingdom (Northern Ireland) · Meloxicam, Meloxicam Farmak Pharmaceuticals Uk
  • Greece · Auroxicam, Brosiral
  • Croatia · Meliam, Movalis
  • Hungary · Camelox, Meloxan
  • Ireland · Areloger
  • Italy · Meloxicam Eg, Meloxicam Mylan Generics
  • Lithuania · Melobax, Melox
  • Luxembourg · Meloxicam Eg, Mobic
  • Latvia · Melox, Mexolan
  • Malta · Melox
  • Netherlands · Meloxicam Aurobindo, Meloxicam Unichem
  • Poland · Aglan, Aspicam
  • Portugal · Meloxicam Almus, Meloxicam Azevedos
  • Romania · Meloxicam Laropharm, Meloxicam Mcc
  • Sweden · Melox
  • Slovenia · Movalis
  • Slovakia · Meloxan, Meloxikam Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/61d92ed8-9d77-45e4-9b71-2eee7ff1b15f
GET /v1/drugs/61d92ed8-9d77-45e4-9b71-2eee7ff1b15f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66904340",
  "date_amm": "2009-08-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MÉLOXICAM",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about meloxicam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.